Skip to main navigation Skip to search Skip to main content

Genentech 2021-02: Pharmacokinetics and Dose Response/Fractionation of GDC-5780 in the murine lung infection model with select enterobacteriaceae isolates

Project Details

StatusFinished
Effective start/end date13/07/2112/07/22

Funding

  • Genentech: $132,530.87

Keywords

  • Biotechnology & Drug Development, Infectious Diseases